Team:British Columbia/Medal

#collab2 {width:270px;float:left; background-color: white; margin-right: 40px;  margin-top:10px;}

<div id=note></br><font face=arial narrow size=4><b>Bronze Medal Requirements</b></br></br></font><font face=arial narrow>

Register the team, have a great summer, and plan to have fun at the Regional Jamboree.</br>

Successfully complete and submit this iGEM 2012 Judging form.</br>

Create and share a Description of the team's project using the iGEM wiki and the team's parts using the Registry of Standard Biological Parts.</br>

Enter information detailing at least one new standard BioBrick Part or Device in the Registry of Standard Biological Parts. Including:</br>

1. Primary nucleic acid sequence</br>

2. Description of function</br>

3. Authorship</br>

4. Safety notes, if relevant</br>

5. Acknowedgment of sources and references</br>

Submit DNA for at least one new BioBrick Part or Device to the Registry.</br>

<div id=note></br><font face=arial narrow size=4><b>Silver Medal Requirements</b></br></br></font><font face=arial narrow>

Demonstrate that at least one new BioBrick Part or Device of your own design and construction works as expected; characterize the operation of your new part/device.</br>

Enter this information and other documentation on the part's 'Main Page' section of the Registry</br>

Part Number(s): <a href=""></a>, <a href=""></a>, <a href=""></a>, <a href=""></a>, <a href=""></a>, <a href=""></a>, <a href=""></a>, <a href=""></a>

<div id=note></br><font face=arial narrow size=4><b>Gold Medal Requirements</b></br></br></font><font face=arial narrow>

<b>Criteria 1: Improve an existing BioBrick Part or Device and enter this information back on the Experience Page of the Registry.</b></br>

We standardized the fluorescent protein BioBricks by putting them under the same constitutive promoters and plasmid. Thereby, we have improved the fluorescent markers by making them into three more usable parts that can be used as a new tool kit for future iGEM teams. </br>

Part Number(s): <a href=""></a>, <a href=""></a>, <a href=""></a></br>

We put inducible promoters in front of TrpA, TyrA and MetA-encoding genes so that they can be utilized in regulating growth in the context of both single organisms and also consortia.</br>Part Number(s): <a href=""></a>, <a href=""></a>, <a href=""></a></br></br>

<b>Criteria 2: Help another iGEM team by, for example, characterizing a part, debugging a construct, or modeling or simulating their system.</b></br>

We helped the University of Calgary team troubleshoot the rhamnose promoter that they were having trouble with and proved that it was not functional through careful experiments. Our two teams also distributed the work of making BioBricks of the DSZ genes.</br></br>

<b>Criteria 3: Outline and detail a new approach to an issue of Human Practice in synthetic biology as it relates to your project, such as safety, security, ethics, or ownership, sharing, and innovation.</b>

<font face=arial narrow size=4><b>Eligibility for Special Prizes</b></br></br></font>

<b>IP survey and guide:</b> We designed and administered an <a href="https://2012.igem.org/Team:British_Columbia/Patent">intellectual property survey</a> to gather high impact data from more than 300 members of the iGEM community. The information was useful to other iGEMers, such as Team INSA Lyon who cited the majority of our data for their human practice. Our team also engaged people outside of the iGEM community, such as a patent agent, patent lawyer, University of British Columbia University-Industry Liaison Office and technical experts.  The end result, with use of feedback from experts and other iGEM teams, was an <a href="https://2012.igem.org/Team:British_Columbia/Human_Practices/IP_FAQ">intellectual property guide</a> geared specifically towards the iGEM competition.</br>

<b>Consortia Model:</b> To model the population dynamics of our engineered consortia, we used wet lab data to improve the accuracy.  Our <a href="https://2012.igem.org/Team:British_Columbia/Consortia">model</a> improves on the two-organism consortia model found in literature by simulating the significantly more complex synthetic three-organism community, which has not yet been done to our knowledge. Furthermore, our model was designed to be easily adaptable to any consortia experiment in general.</br>

<b>Calgary</b>:</br>Calgary submitted and characterized DszA and DszB, and UBC submitted and characterized DszC and DszD of the Dsz operon. More details <a href="https://2012.igem.org/Team:British_Columbia/Attributions">here</a> on our attributions page.</div>

<b>TU Munich</b>:</br>We participated in TU Munich's survey on the improvement of part descriptions.</br></br>

<html></div><div id=collab2><b>INSA Lyon</b>:</br>